Multiple endocrine neoplasia type 1 with ectopic parathyroid adenoma

Multiple endocrine neoplasia type 1 (MEN1) syndrome, also known as Wermer’s syndrome, is a rare, autosomal dominant inherited syndrome caused by mutations in the MEN-1 tumor suppressor gene [1, 2]. The estimated prevalence of MEN1 syndrome is 1 : 30,000 in the general population [1]. This low frequency is the main reason for the rarity of controlled clinical trials. Patients can be diagnosed with MEN1 when 2 or more primary endocrine tumors, including pituitary tumors, pancreatic tumors, and parathyroid adenomas, are present. Among them, the most common pathological type is parathyroid adenoma with primary hyperparathyroidism (HPT). MEN1 with HPT is characterized by asynchronous and asymmetrical growth of the parathyroid glands. Ectopic parathyroid adenomas can also be observed in MEN1 patients, which can be easily misdiagnosed. In the present case, we report a man with persistent HPT, who was diagnosed with MEN1 based on the results of a genetic study. He was found to have an ectopic parathyroid adenoma in the retroesophageal region, which was the main gland to affect HPT. of a a

[1]  Y. Hwang,et al.  A rare case of multiple endocrine neoplasia type 1 initially presenting as an asymptomatic, huge mediastinal mass: case report , 2021, BMC Endocrine Disorders.

[2]  N. Tandon,et al.  Multiple Endocrine Neoplasia Type 1 Syndrome: A Case Report and Review of Literature , 2020, Cureus.

[3]  H. Chae,et al.  A case of primary hyperparathyroidism due to an intrathymic ectopic parathyroid adenoma in a 15-year-old boy , 2020, Annals of pediatric endocrinology & metabolism.

[4]  B. Robinson,et al.  Multiple endocrine neoplasia: an update , 2019, Internal medicine journal.

[5]  C. Stratakis,et al.  Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis , 2019, Front. Endocrinol..

[6]  Wenke Liu,et al.  Primary hyperparathyroidism due to ectopic parathyroid adenoma in an adolescent: a case report and review of the literature , 2019, Endocrine.

[7]  A. Al-Salameh,et al.  Update on multiple endocrine neoplasia Type 1 and 2. , 2018, Presse medicale.

[8]  S. Agarwal The future: genetics advances in MEN1 therapeutic approaches and management strategies. , 2017, Endocrine-related cancer.

[9]  A. Falchetti Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old , 2017, F1000Research.

[10]  S. Kim,et al.  Multiple endocrine neoplasia type 1 with anterior mediastinal parathyroid adenoma: successful localization using Tc-99m sestamibi SPECT/CT , 2016, Annals of surgical treatment and research.

[11]  M. Brandi,et al.  Aortopulmonary window parathyroid gland causing primary hyperparathyroidism in men type 1 syndrome , 2015, Familial Cancer.

[12]  A. Tabarin,et al.  MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines. , 2015, The Journal of clinical endocrinology and metabolism.

[13]  Ashutosh Goyal,et al.  A challenging case of an ectopic parathyroid adenoma , 2012, Indian journal of endocrinology and metabolism.

[14]  J. Bilezikian,et al.  Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.

[15]  Herb Chen,et al.  Incidence and Localization of Ectopic Parathyroid Adenomas in Previously Unexplored Patients , 2012, World Journal of Surgery.

[16]  H. Gharib,et al.  Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2. , 1993, Surgery.